[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fh-fe_gdKbdkQr4_wYDlwqD30EyYg6iVZayF8K3tDw4s":3},{"code":4,"msg":5,"data":6},200,"操作成功",{"id":7,"title":8,"content":9,"digest":10,"source":10,"coverPath":11,"thumbsCoverPath":12,"isTop":13,"isShow":14,"baseClick":13,"clickCount":15,"createTime":16,"typeId":17,"isNewest":18,"newsInfoTypeRespVo":19,"voiceUrl":22,"voiceSize":23,"taskId":24,"releaseTime":25,"titleEn":26,"contentEn":27,"voiceUrlEn":28,"taskIdEn":29,"voiceSizeEn":30},2058,"芯位伙伴 | 依托中德科创协作纽带｜再生技术专委会联合积水潭医院借力史太白深化中德再生医学国际合作","\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">2026年6月3日，中国医疗技术行业协会再生技术分会副主任委员、北京积水潭医院孙磊教授带队到访史太白，开展再生医学领域专项座谈交流会，重点围绕骨再生技术中德国际合作、技术攻关及产业化落地开展深度研讨。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">会上，参会各方聚焦国内骨再生技术发展现状与产业需求展开交流。大家认为，当前国内再生医学产业化发展亟需整合海外高端技术与专家资源，将依托史太白全球化科创平台优势，精准对接德国智库专家、生物医药研发资源与产业落地载体，围绕技术迭代优化、临床对照试验、医疗器械合规验证等关键环节推进跨国协同合作，加速前沿再生医疗技术成果落地应用、实现市场化转化。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">中国医疗技术行业协会再生技术分会副主任委员、北京积水潭医院孙磊教授表示，再生医学是我国生物医药重点扶持赛道，畅通中德双边技术互通、产学研联动合作渠道，是行业高质量发展的必然需求。本次座谈搭建了良好的沟通桥梁，为专委会后续常态化开展国际学术交流、推进务实项目合作奠定了坚实基础。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">史太白中国国际部总经理李丽出席座谈并致辞。她表示，史太白长期深耕中德科创成果转化领域，依托德国本土科研院所、行业协会及龙头企业资源，搭建了成熟的跨国技术落地服务体系。未来，平台将充分发挥资源优势，精准对接中德双方优质资源，补齐国内再生医学成果转化短板，持续推进学术研讨、技术引进、项目共建等多元合作，助力国内再生医学产业提质升级、创新发展。\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp>【新闻来源】史太白公众号  https:\u002F\u002Fmp.weixin.qq.com\u002Fs\u002FodhQ88UaKULUvV9QkcG3EQ\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">（本网转发此文章，旨在为读者提供更多的信息资讯，所涉内容不构成投资、消费建议。文章事实如有疑问，请与有关方核实，文章观点非本网观点，仅供读者参考。）\u003C\u002Fp>","","https:\u002F\u002Fimage.51xinwei.com\u002F2026\u002F06\u002F27e0a564061a4e07be2c779192140075\u002F跨界校园.png","https:\u002F\u002Fimage.51xinwei.com\u002F2026\u002F06\u002Fthumbs\u002F27e0a564061a4e07be2c779192140075\u002F跨界校园.png",0,1,35,"2026-06-11 10:33",5,false,{"id":17,"name":20,"enName":21},"跨界校园","Trans-Sectoral Campus","https:\u002F\u002Fxinwei-dev-test.oss-cn-shenzhen.aliyuncs.com\u002Fintelligent\u002Faudio%3A85609d74-143f-43af-9afc-fa70cafc7d5b%3A0.wav?Expires=1781148957&OSSAccessKeyId=LTAI5tNvY2RkKjZw4LLWsrPK&Signature=YVWETQ%2F%2FTznJxXqRleKCteH24yk%3D",3490854,"85609d74-143f-43af-9afc-fa70cafc7d5b","2026-06-11 10:31","XINWEI Partner | Relying on China-Germany Science and Technology Collaboration Link｜Regeneration Technology Committee Collaborates with Jishuitan Hospital to Deepen China-Germany Regenerative Medicine International Cooperation via Steinbeis","\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">On June 3, 2026, led by Professor Sun Lei, Deputy Director of the Regeneration Technology Branch of the China Medical Technology Industry Association and professor at Beijing Jishuitan Hospital, a delegation visited Steinbeis for a specialized symposium and exchange meeting in the field of regenerative medicine. The discussions focused on in-depth exploration of China-Germany international cooperation in bone regeneration technology, technical breakthroughs, and industrialization implementation.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">During the meeting, participants exchanged views on the current development status and industrial demands of domestic bone regeneration technology. It was widely recognized that the industrialization of regenerative medicine in China urgently requires the integration of high-end overseas technology and expert resources. Leveraging the advantages of Steinbeis's global science and innovation platform, precise connections will be established with German think-tank experts, biopharmaceutical R&D resources, and industrial implementation carriers. Cross-border collaborative cooperation will be promoted in key areas such as technology iteration and optimization, clinical control trials, and compliance verification of medical devices, to accelerate the application and market transformation of cutting-edge regenerative medical technology achievements.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">Professor Sun Lei, Deputy Director of the Regeneration Technology Branch of the China Medical Technology Industry Association and professor at Beijing Jishuitan Hospital, stated that regenerative medicine is a key supported sector in China's biopharmaceutical industry. Facilitating bilateral technology exchange and industry-university-research collaboration channels between China and Germany is an inevitable requirement for the high-quality development of the industry. This symposium has established a solid communication bridge, laying a strong foundation for the committee's future regular international academic exchanges and the promotion of practical project cooperation.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cspan style=\"font-size: 20px;\">Li Li, General Manager of Steinbeis China International Department, attended the symposium and delivered a speech. She stated that Steinbeis has long been deeply involved in the field of China-Germany science and technology achievement transformation. Relying on resources from German research institutes, industry associations, and leading enterprises, it has established a mature transnational technology implementation service system. In the future, the platform will fully leverage its resource advantages to precisely connect high-quality resources from both China and Germany, address shortcomings in the transformation of domestic regenerative medicine achievements, and continuously advance diverse cooperation such as academic seminars, technology introduction, and joint project development, contributing to the quality improvement, upgrading, and innovative development of China's regenerative medicine industry.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">\u003Cbr>\u003C\u002Fp>\u003Cp>【News Source】Steinbeis WeChat Official Account https:\u002F\u002Fmp.weixin.qq.com\u002Fs\u002FodhQ88UaKULUvV9QkcG3EQ\u003C\u002Fp>\u003Cp class=\"ql-align-justify\">(This website reposts this article to provide readers with more information. The content involved does not constitute investment or consumption advice. If there are any questions regarding the facts in the article, please verify with the relevant parties. The views expressed in the article are not the views of this website and are for reference only.)\u003C\u002Fp>","https:\u002F\u002Fxinwei-dev-test.oss-cn-shenzhen.aliyuncs.com\u002Fintelligent\u002Faudio%3A5db39f55-884c-472a-8fd0-0c6ed8a9b37a%3A0.wav?Expires=1781148957&OSSAccessKeyId=LTAI5tNvY2RkKjZw4LLWsrPK&Signature=vnfMin54SBfKj6%2FbGO1%2FHhyJ4Vg%3D","5db39f55-884c-472a-8fd0-0c6ed8a9b37a",5866820]